These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31304530)

  • 21. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
    Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
    J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
    Orsi GB; Di Stefano L; Noah N
    Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correcting for bias when estimating the cost of hospital-acquired infection: an analysis of lower respiratory tract infections in non-surgical patients.
    Graves N; Weinhold D; Roberts JA
    Health Econ; 2005 Jul; 14(7):755-61. PubMed ID: 15678521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Magnitude of Time-Dependent Bias in the Estimation of Excess Length of Stay Attributable to Healthcare-Associated Infections.
    Nelson RE; Nelson SD; Khader K; Perencevich EL; Schweizer ML; Rubin MA; Graves N; Harbarth S; Stevens VW; Samore MH
    Infect Control Hosp Epidemiol; 2015 Sep; 36(9):1089-94. PubMed ID: 26041436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.
    Kirkland KB; Briggs JP; Trivette SL; Wilkinson WE; Sexton DJ
    Infect Control Hosp Epidemiol; 1999 Nov; 20(11):725-30. PubMed ID: 10580621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring the in-hospital costs of Pseudomonas aeruginosa pneumonia: methodology and results from a German teaching hospital.
    Kaier K; Heister T; Götting T; Wolkewitz M; Mutters NT
    BMC Infect Dis; 2019 Dec; 19(1):1028. PubMed ID: 31795953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.
    Pittet D; Tarara D; Wenzel RP
    JAMA; 1994 May; 271(20):1598-601. PubMed ID: 8182812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of nosocomial infections on medical costs, hospital stay, and outcome in hospitalized patients.
    Sheng WH; Chie WC; Chen YC; Hung CC; Wang JT; Chang SC
    J Formos Med Assoc; 2005 May; 104(5):318-26. PubMed ID: 15959598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of multistate model, survival regression, and matched case-control methods for estimating excess length of stay due to healthcare-associated infections.
    Pan J; Kavanagh K; Stewart S; Robertson C; Kennedy S; Manoukian S; Haahr L; Graves N; Reilly J
    J Hosp Infect; 2022 Aug; 126():44-51. PubMed ID: 35500765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of Extra Length of Stay Attributable to Hospital-Acquired Infections in Adult ICUs Using a Time-Dependent Multistate Model.
    Ohannessian R; Gustin MP; Bénet T; Gerbier-Colomban S; Girard R; Argaud L; Rimmelé T; Guerin C; Bohé J; Piriou V; Vanhems P
    Crit Care Med; 2018 Jul; 46(7):1093-1098. PubMed ID: 29642107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating length of stay and inpatient charges attributable to hospital-acquired bloodstream infections.
    Zhang Y; Du M; Johnston JM; Andres EB; Suo J; Yao H; Huo R; Liu Y; Fu Q
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):137. PubMed ID: 32811557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating extra length of stay due to healthcare-associated infections before and after implementation of a hospital-wide infection control program.
    Arefian H; Hagel S; Fischer D; Scherag A; Brunkhorst FM; Maschmann J; Hartmann M
    PLoS One; 2019; 14(5):e0217159. PubMed ID: 31100094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model.
    Stewardson A; Fankhauser C; De Angelis G; Rohner P; Safran E; Schrenzel J; Pittet D; Harbarth S
    Infect Control Hosp Epidemiol; 2013 Feb; 34(2):133-43. PubMed ID: 23295559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare associated infections in Paediatric Intensive Care Unit of a tertiary care hospital in India: Hospital stay & extra costs.
    Sodhi J; Satpathy S; Sharma DK; Lodha R; Kapil A; Wadhwa N; Gupta SK
    Indian J Med Res; 2016 Apr; 143(4):502-6. PubMed ID: 27377508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
    Classen DC; Pestotnik SL; Evans RS; Lloyd JF; Burke JP
    JAMA; 1997 Jan 22-29; 277(4):301-6. PubMed ID: 9002492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of the costs of hospital infection by prevalence surveys.
    French GL; Cheng AF
    J Hosp Infect; 1991 Jun; 18 Suppl A():65-72. PubMed ID: 1679829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic impact of healthcare-associated rotavirus infection in a paediatric hospital.
    Piednoir E; Bessaci K; Bureau-Chalot F; Sabouraud P; Brodard V; Andréoletti L; Bajolet O
    J Hosp Infect; 2003 Nov; 55(3):190-5. PubMed ID: 14572486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attributable costs and length of stay of hospital-acquired
    Leal JR; Conly J; Weaver R; Wick J; Henderson EA; Manns B; Ronksley P
    Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1135-1143. PubMed ID: 31342884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Estimation of costs attributable to nosocomial infection: prolongation of hospitalization and calculation of alternative costs].
    Peña C; Pujol M; Pallarés R; Corbella X; Vidal T; Tortras N; Ariza J; Gudiol F
    Med Clin (Barc); 1996 Mar; 106(12):441-4. PubMed ID: 8656728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct medical burden of antimicrobial-resistant healthcare-associated infections: empirical evidence from China.
    Liu X; Cui D; Li H; Wang Q; Mao Z; Fang L; Ren N; Sun J
    J Hosp Infect; 2020 Jun; 105(2):295-305. PubMed ID: 31931043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.